Navigation Links
Boston Biotech R&D Conference to Showcase Next-Generation Newsmakers and Massachusetts as Leader in Biotech Discovery
Date:10/1/2009

Oct. 27 Event Kicks Off With Keynote by Investor and New England Patriots President Jonathan Kraft

Boston, MA (Vocus) September 30, 2009 -- The Boston biotechnology industry will get an early look at biotech's future value-drivers and newsmakers at the 2009 Boston Biotech R&D Conference on October 27, 2009 at Harvard Medical School.

At the one-day event, recently funded companies will present their science and platforms for the first time to a limited audience of 100 venture capitalists and pharmaceutical executives. The second annual conference will open with a keynote address by Jonathan Kraft, president of the New England Patriots, and president and chief executive officer of The Kraft Group, a group of privately held companies in professional sports, manufacturing and real estate investment.

"This will be an important gathering of the brightest minds in Boston's biotech research and development to shine a spotlight on their novel science and technology platforms," said Christoph Westphal, M.D., Ph.D., chief executive officer of Sirtris, a GSK company and senior vice president of the Center of Excellence for External Drug Discovery (CEEDD), GSK. "Thanks to the success of last year's inaugural R&D Conference, we received interest from biotech companies from across the country to participate in this year's conference, which reinforces Massachusetts' standing in the industry on a global scale."

Westphal founded the Boston Biotech Conference series four years ago, which includes the annual Boston Biotech Business Development Conference in April and Boston Biotech CEO Conference in June. In its second year, the R&D Conference is designed to showcase the next generation of leading biotech and pharmaceutical companies from the Boston area.

According to conference sponsor MassBio, the state continues to be a leader in the nation's biotech industry. With the number of Massachusetts residents working in the biotech industry at an all time high, companies in the state account for 6.4 percent of drugs in the pipeline globally, and next to California, Massachusetts is the best funded state for biotech venture capital investment.
"The Boston Biotech Conference series is one of the highlights of the year for our industry, as it offers an early look at the regional R&D success stories we are likely to read about in the upcoming year," said President & CEO of MassBio Robert K. Coughlin. "It's gatherings like these that help to spur the innovation and investment, which makes Massachusetts' biotechnology industry a global leader."

ABOUT THE BOSTON BIOTECH R&D CONFERENCE
The 2009 Boston Biotech R&D Conference will highlight up-and-coming biotech companies in the Boston area. The agenda features several luminaries in medicine and research, as well as executives of the next generation of leading biotech and pharma companies from the Boston area. Jonathan Kraft president and chief executive officer of The Kraft Group and president of the New England Patriots, will provide the keynote address. The conference is being organized by Christoph Westphal, M.D., Ph.D., Chief Executive Officer of Sirtris, a GSK company and Senior Vice President of the Center of Excellence for External Drug Discovery (CEEDD), GSK and Michelle Dipp, M.D., Ph.D., Vice President, Head of U.S. CEEDD, GSK. The conference is sponsored by Alexandria Real Estate Equities, Clinquest, MassBio, Massachusetts Life Sciences Center, Merriman Curhan Ford & Co. and Pure Communications, Inc. For more information or to register for the conference, visit www.bostonbiotechconference.com.

###

Read the full story at http://www.prweb.com/releases/boston_biotech/conference/prweb2973464.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan
4. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
5. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
6. Boston Scientific Announces Election of Ray Elliott to Its Board of Directors
7. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
8. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System
9. Genzyme Begins Major Expansion of Boston Manufacturing Facility
10. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
11. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... ... June 22, 2017 , ... Charm Sciences, Inc. is ... AMPH test was determined to be appropriate as a screening test at dairies and ... the Charm EZ system, and the Charm EZ Lite system. These systems are a ...
(Date:6/20/2017)... ... ... Biologist Dawn Maslar MS has found a biomarker that she claims verifies ... The Neuroscience of Meeting, Dating, Losing Your Mind, and Finding True Love, Maslar found ... step, in my estimation, was to scientifically track the evidence of commitment in men,” ...
(Date:6/20/2017)... , June 20, 2017  Kibow Biotech Inc., a ... announce the issuance of a new patent covering a ... by the U.S. Patent and Trademark Office on May ... of the Buzz of Bio award in 2014 in ... to developing non-drug approaches to chronic disease. Renadyl™, the ...
(Date:6/20/2017)... ... June 20, 2017 , ... Do More with OHAUS , With the ... trusted supplier in the weighing industry, to extending its expertise across the entire laboratory ... immunoassays, hybridizations and more, allowing for its customers to 'Do More' in ...
Breaking Biology Technology:
(Date:4/5/2017)... KEY FINDINGS The global market for stem ... 25.76% during the forecast period of 2017-2025. The rise ... growth of the stem cell market. Download ... The global stem cell market is segmented on the ... cell market of the product is segmented into adult ...
(Date:3/30/2017)...  On April 6-7, 2017, Sequencing.com will host the ... hackathon at Microsoft,s headquarters in Redmond, Washington ... developing health and wellness apps that provide a unique, ... is the first hackathon for personal genomics and ... in the genomics, tech and health industries are sending ...
(Date:3/29/2017)... , March 29, 2017  higi, the health ... in North America , today announced ... and the acquisition of EveryMove. The new investment and ... set of tools to transform population health activities through ... lifestyle data. higi collects and secures data ...
Breaking Biology News(10 mins):